Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Harmony Biosciences stock | $31.96

Learn how to easily invest in Harmony Biosciences stock.

Harmony Biosciences Holdings, Inc
-$0.06 (-0.23%)

Harmony Biosciences Holdings, Inc is a biotechnology business based in the US. Harmony Biosciences shares (HRMY) are listed on the NASDAQ and all prices are listed in US Dollars. Harmony Biosciences employs 150 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Harmony Biosciences

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – HRMY – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Harmony Biosciences stock price (NASDAQ: HRMY)

Use our graph to track the performance of HRMY stocks over time.

Harmony Biosciences shares at a glance

Information last updated 2021-07-23.
Latest market close$31.96
52-week range$25.46 - $52.74
50-day moving average $30.40
200-day moving average $32.12
Wall St. target price$52.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) N/A

Buy Harmony Biosciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs
Get one free stock valued between $3.00 and $300 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month
Download and sign up with; approved accounts receive a free stock slice worth up to $70, selected from 9 popular stocks.
Open an account
Commission-free trading in stocks and ETFs with a social networking twist.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Stocks, Options, ETFs
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Stocks, Options, ETFs
$0 per year
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Harmony Biosciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Harmony Biosciences price performance over time

Historical closes compared with the close of $31.96 from 2021-05-28

1 week (2021-07-20) N/A
1 month (2021-07-01) 8.67%
3 months (2021-04-30) 9.08%
6 months (2021-01-27) N/A
1 year (2020-07-27) N/A
2 years (2019-07-27) N/A
3 years (2018-07-27) N/A
5 years (2016-07-27) N/A

Is Harmony Biosciences under- or over-valued?

Valuing Harmony Biosciences stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Harmony Biosciences's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

Harmony Biosciences's EBITDA

Harmony Biosciences's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $54.2 million.

The EBITDA is a measure of a Harmony Biosciences's overall financial performance and is widely used to measure a its profitability.

Harmony Biosciences financials

Revenue TTM $199.6 million
Operating margin TTM 20.61%
Gross profit TTM $132 million
Return on assets TTM 10.27%
Return on equity TTM 29.38%
Profit margin 4.54%
Book value $1.90
Market capitalisation $1.7 billion

TTM: trailing 12 months

Shorting Harmony Biosciences shares

There are currently 919,738 Harmony Biosciences shares held short by investors – that's known as Harmony Biosciences's "short interest". This figure is 53.9% up from 597,743 last month.

There are a few different ways that this level of interest in shorting Harmony Biosciences shares can be evaluated.

Harmony Biosciences's "short interest ratio" (SIR)

Harmony Biosciences's "short interest ratio" (SIR) is the quantity of Harmony Biosciences shares currently shorted divided by the average quantity of Harmony Biosciences shares traded daily (recently around 326148.22695035). Harmony Biosciences's SIR currently stands at 2.82. In other words for every 100,000 Harmony Biosciences shares traded daily on the market, roughly 2820 shares are currently held short.

However Harmony Biosciences's short interest can also be evaluated against the total number of Harmony Biosciences shares, or, against the total number of tradable Harmony Biosciences shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Harmony Biosciences's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Harmony Biosciences shares in existence, roughly 20 shares are currently held short) or 0.0412% of the tradable shares (for every 100,000 tradable Harmony Biosciences shares, roughly 41 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Harmony Biosciences.

Find out more about how you can short Harmony Biosciences stock.

Harmony Biosciences share dividends

We're not expecting Harmony Biosciences to pay a dividend over the next 12 months.

Harmony Biosciences overview

Harmony Biosciences Holdings, Inc. , a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy in the United States. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc.

Frequently asked questions

What percentage of Harmony Biosciences is owned by insiders or institutions?
Currently 18.847% of Harmony Biosciences shares are held by insiders and 75.636% by institutions.
How many people work for Harmony Biosciences?
Latest data suggests 150 work at Harmony Biosciences.
When does the fiscal year end for Harmony Biosciences?
Harmony Biosciences's fiscal year ends in December.
Where is Harmony Biosciences based?
Harmony Biosciences's address is: 630 West Germantown Pike, Plymouth Meeting, PA, United States, 19462
What is Harmony Biosciences's ISIN number?
Harmony Biosciences's international securities identification number is: US4131971040

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site